Capital Counsel’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $326K | Sell |
804
-323
| -29% | -$131K | 0.01% | 42 |
|
2025
Q1 | $561K | Sell |
1,127
-50
| -4% | -$24.9K | 0.02% | 36 |
|
2024
Q4 | $612K | Hold |
1,177
| – | – | 0.03% | 34 |
|
2024
Q3 | $728K | Hold |
1,177
| – | – | 0.03% | 33 |
|
2024
Q2 | $651K | Sell |
1,177
-16
| -1% | -$8.85K | 0.03% | 35 |
|
2024
Q1 | $693K | Buy |
1,193
+445
| +59% | +$259K | 0.03% | 34 |
|
2023
Q4 | $397K | Sell |
748
-55
| -7% | -$29.2K | 0.02% | 39 |
|
2023
Q3 | $406K | Buy |
803
+5
| +0.6% | +$2.53K | 0.02% | 37 |
|
2023
Q2 | $416K | Sell |
798
-32
| -4% | -$16.7K | 0.02% | 37 |
|
2023
Q1 | $478K | Hold |
830
| – | – | 0.03% | 36 |
|
2022
Q4 | $457K | Sell |
830
-20
| -2% | -$11K | 0.03% | 35 |
|
2022
Q3 | $431K | Sell |
850
-15
| -2% | -$7.61K | 0.03% | 38 |
|
2022
Q2 | $470K | Hold |
865
| – | – | 0.03% | 38 |
|
2022
Q1 | $511K | Sell |
865
-146
| -14% | -$86.3K | 0.02% | 41 |
|
2021
Q4 | $675K | Sell |
1,011
-56
| -5% | -$37.4K | 0.03% | 37 |
|
2021
Q3 | $610K | Hold |
1,067
| – | – | 0.03% | 38 |
|
2021
Q2 | $538K | Hold |
1,067
| – | – | 0.03% | 41 |
|
2021
Q1 | $487K | Hold |
1,067
| – | – | 0.03% | 45 |
|
2020
Q4 | $497K | Hold |
1,067
| – | – | 0.03% | 43 |
|
2020
Q3 | $471K | Hold |
1,067
| – | – | 0.03% | 42 |
|
2020
Q2 | $387K | Hold |
1,067
| – | – | 0.03% | 45 |
|
2020
Q1 | $303K | Hold |
1,067
| – | – | 0.02% | 48 |
|
2019
Q4 | $347K | Buy |
1,067
+32
| +3% | +$10.4K | 0.02% | 50 |
|
2019
Q3 | $301K | Hold |
1,035
| – | – | 0.02% | 50 |
|
2019
Q2 | $304K | Hold |
1,035
| – | – | 0.02% | 50 |
|
2019
Q1 | $283K | Hold |
1,035
| – | – | 0.02% | 52 |
|
2018
Q4 | $232K | Hold |
1,035
| – | – | 0.02% | 54 |
|
2018
Q3 | $253K | Hold |
1,035
| – | – | 0.02% | 58 |
|
2018
Q2 | $214K | Buy |
+1,035
| New | +$214K | 0.02% | 56 |
|